masthead-news

News & Events

HTG Molecular Diagnostics Reports Third Quarter 2019 Results

 Product and product-related services revenue increased by 228% and 125% in the three and nine-month periods, respectively, compared to the prior year periods Call scheduled for today, November 12 , at 4:30pm ET TUCSON, Ariz. , Nov. 12, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc.

Read More

Posted on:
 

HTG Molecular Diagnostics Announces Pricing of $20.0 Million Aggregate Financing, Consisting of $16.6 Million Public Offering of Common Stock and $3.5 Million Concurrent Private Placement

TUCSON, Ariz. –(BUSINESS WIRE)–Sep. 20, 2019– HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced the pricing of an underwritten public offering of 25,476,989 shares of its common stock at a price to the

Read More

Posted on:
 

Page last updated September 29, 2020